产品
编 号:F279786
分子式:C11H16ClN5O3
分子量:301.73
产品类型
结构图
CAS No: 222631-44-9
联系客服
产品详情
生物活性:
Galidesivir (BCX4430) hydrochloride, an adenosine analog and a direct-acting antiviral agent, disrupts viral RNA-dependent RNA polymerase (RdRp) activity. Galidesivir hydrochloride is active in vitro against many RNA viral pathogens, including the filoviruses and emerging infectious agents such as MERS-CoV, SARS-CoV, and SARS-CoV-2. Galidesivir hydrochloride inhibits some negative-sense RNA viruses with EC50s ranging from ~3 to ~68 μM.
体内研究:
Galidesivir (BCX4430) hydrochloride 在肌内、腹膜内和口服给药后在各种实验性感染中具有活性。在涉及埃博拉病毒、马尔堡病毒、裂谷热病毒和黄热病病毒的致死性感染的非临床研究中,盐酸加利德韦显示出显著的疗效。盐酸加利德韦 (4 mg/kg;腹腔注射;每天两次,持续 7 天) 在黄热病 (YF) 仓鼠模型中有效。Animal Model:Female Syrian golden hamsters (hamsters infected with YF virus)
Dosage:4 mg/kg of body weight
Administration:I.p.; twice daily for 7 days
Result:Significantly improved the survival of hamsters infected with YFV.
体外研究:
细胞激酶将 Galidesivir (BCX4430) 盐酸盐磷酸化为模拟 ATP 的三磷酸盐;病毒 RNA 聚合酶将药物的单磷酸核苷酸整合到生长的 RNA 链中,导致链过早终止。 Galidesivir hydrochloride 有效抑制 YFV 对 Vero 细胞的感染。中性红摄取测定法测定的 EC50 为 8.3 μg/mL (24.5 μM)。